SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-10-128514
Filing Date
2010-05-26
Accepted
2010-05-25 21:21:43
Documents
1
Group Members
DANIEL S. OCHOCH-ZIFF CAPITAL MANAGEMENT GROUP LLCOCH-ZIFF HOLDING CORPORATION

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D dsc13da.htm SC 13D/A 117464
  Complete submission text file 0001193125-10-128514.txt   119642
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-37954 | Film No.: 10858180
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 9 WEST 57TH STREET, 39TH FLOOR NEW YORK NY 10019
Business Address 9 WEST 57TH STREET, 39TH FLOOR NEW YORK NY 10019 2127900165
OZ MANAGEMENT LP (Filed by) CIK: 0001054587 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A